Hologic, Inc. (0J5Q.L)
USD 58.11
(0.96%)
USD 58.11
(0.96%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 374.4 Million USD | 291.22% |
| 2023 | 95.7 Million USD | -83.56% |
| 2022 | 582.1 Million USD | -70.52% |
| 2021 | 1.97 Billion USD | -19.29% |
| 2020 | 2.44 Billion USD | -2.52% |
| 2019 | 2.5 Billion USD | -6.96% |
| 2018 | 2.69 Billion USD | -5.15% |
| 2017 | 2.84 Billion USD | 0.32% |
| 2016 | 2.83 Billion USD | -10.15% |
| 2015 | 3.15 Billion USD | -11.52% |
| 2014 | 3.56 Billion USD | -11.23% |
| 2013 | 4.01 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 104 Million USD | -73.23% |
| 2024 Q2 | 388.5 Million USD | -39.85% |
| 2024 Q1 | 645.9 Million USD | 255.67% |
| 2024 Q4 | 374.4 Million USD | 260.0% |
| 2023 Q3 | 75.2 Million USD | -71.25% |
| 2023 Q4 | 181.6 Million USD | 141.49% |
| 2023 FY | 181.6 Million USD | -68.8% |
| 2023 Q1 | 406.4 Million USD | -30.18% |
| 2023 Q2 | 261.6 Million USD | -35.63% |
| 2022 Q1 | 1.67 Billion USD | -15.31% |
| 2022 FY | 582.1 Million USD | -70.52% |
| 2022 Q4 | 582.1 Million USD | 24.06% |
| 2022 Q3 | 469.2 Million USD | -41.52% |
| 2022 Q2 | 802.3 Million USD | -52.02% |
| 2021 Q1 | 1.94 Billion USD | -20.48% |
| 2021 Q3 | 2.31 Billion USD | 16.91% |
| 2021 Q4 | 1.97 Billion USD | -14.67% |
| 2021 FY | 1.97 Billion USD | -19.29% |
| 2021 Q2 | 1.97 Billion USD | 1.85% |
| 2020 Q3 | 2.66 Billion USD | -6.9% |
| 2020 Q4 | 2.44 Billion USD | -8.4% |
| 2020 FY | 2.44 Billion USD | -2.52% |
| 2020 Q1 | 2.79 Billion USD | 11.4% |
| 2020 Q2 | 2.86 Billion USD | 2.64% |
| 2019 Q3 | 2.64 Billion USD | -3.08% |
| 2019 FY | 2.5 Billion USD | -6.96% |
| 2019 Q4 | 2.5 Billion USD | -5.26% |
| 2019 Q2 | 2.72 Billion USD | -3.78% |
| 2019 Q1 | 2.83 Billion USD | 5.3% |
| 2018 FY | 2.69 Billion USD | -5.15% |
| 2018 Q3 | 2.69 Billion USD | -2.36% |
| 2018 Q4 | 2.69 Billion USD | 0.03% |
| 2018 Q1 | 2.68 Billion USD | -5.33% |
| 2018 Q2 | 2.75 Billion USD | 2.63% |
| 2017 FY | 2.84 Billion USD | 0.32% |
| 2017 Q1 | 2.67 Billion USD | -5.47% |
| 2017 Q2 | 2.17 Billion USD | -18.85% |
| 2017 Q3 | 2.65 Billion USD | 22.26% |
| 2017 Q4 | 2.83 Billion USD | 6.91% |
| 2016 FY | 2.83 Billion USD | -10.15% |
| 2016 Q4 | 2.83 Billion USD | -5.0% |
| 2016 Q3 | 2.98 Billion USD | -3.52% |
| 2016 Q2 | 3.08 Billion USD | 3.6% |
| 2016 Q1 | 2.98 Billion USD | -5.48% |
| 2015 FY | 3.15 Billion USD | -11.52% |
| 2015 Q4 | 3.15 Billion USD | 3.19% |
| 2015 Q3 | 3.05 Billion USD | -6.48% |
| 2015 Q2 | 3.26 Billion USD | -4.15% |
| 2015 Q1 | 3.41 Billion USD | -4.34% |
| 2014 FY | 3.56 Billion USD | -11.23% |
| 2014 Q4 | 3.56 Billion USD | -1.99% |
| 2014 Q3 | 3.63 Billion USD | -3.98% |
| 2014 Q2 | 3.78 Billion USD | -1.82% |
| 2014 Q1 | 3.85 Billion USD | -3.92% |
| 2013 Q4 | 4.01 Billion USD | -0.72% |
| 2013 Q3 | 4.04 Billion USD | -5.01% |
| 2013 Q2 | 4.25 Billion USD | 692.88% |
| 2013 Q1 | -718.47 Million USD | 0.0% |
| 2013 FY | 4.01 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 595.651% |
| Accuray Incorporated | 103.58 Million USD | -261.439% |
| Align Technology, Inc. | -840.47 Million USD | 144.547% |
| Elevance Health Inc. | 18.59 Billion USD | 97.986% |
| AxoGen, Inc. | 32.26 Million USD | -1060.355% |
| Boston Scientific Corporation | 8.23 Billion USD | 95.452% |
| CVS Health Corporation | 71.18 Billion USD | 99.474% |
| Cardinal Health, Inc. | 476 Million USD | 21.345% |
| Centene Corporation | 506 Million USD | 26.008% |
| DaVita Inc. | 10.65 Billion USD | 96.485% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 99.085% |
| Humana Inc. | 5.51 Billion USD | 93.216% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 24.203% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 93.089% |
| Masimo Corporation | 804 Million USD | 53.433% |
| McKesson Corporation | 889 Million USD | 57.885% |
| Patterson Companies, Inc. | 648.47 Million USD | 42.265% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 92.005% |
| ResMed Inc. | 635.57 Million USD | 41.093% |
| Henry Schein, Inc. | 2.57 Billion USD | 85.432% |
| Teladoc Health, Inc. | 468.6 Million USD | 20.103% |
| Universal Health Services, Inc. | 5.24 Billion USD | 92.865% |
| Veeva Systems Inc. | -647.71 Million USD | 157.803% |
| Baxter International Inc. | 11.16 Billion USD | 96.647% |
| Becton, Dickinson and Company | 14.46 Billion USD | 97.411% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 114.074% |
| Danaher Corporation | 13.49 Billion USD | 97.225% |
| Stryker Corporation | 10.02 Billion USD | 96.265% |
| Medtronic plc | 23.67 Billion USD | 98.419% |